Intellipharmaceutics International Stock Current Liabilities
Intellipharmaceutics International fundamentals help investors to digest information that contributes to Intellipharmaceutics' financial success or failures. It also enables traders to predict the movement of Intellipharmaceutics OTC Stock. The fundamental analysis module provides a way to measure Intellipharmaceutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Intellipharmaceutics otc stock.
Intellipharmaceutics |
Intellipharmaceutics International OTC Stock Current Liabilities Analysis
Intellipharmaceutics' Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.
Current Intellipharmaceutics Current Liabilities | 7.02 M |
Most of Intellipharmaceutics' fundamental indicators, such as Current Liabilities, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Intellipharmaceutics International is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
CompetitionIn accordance with the recently published financial statements, Intellipharmaceutics International has a Current Liabilities of 7.02 M. This is 99.6% lower than that of the Pharmaceuticals sector and 98.71% lower than that of the Health Care industry. The current liabilities for all United States stocks is 99.91% higher than that of the company.
Intellipharmaceutics Current Liabilities Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Intellipharmaceutics' direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Intellipharmaceutics could also be used in its relative valuation, which is a method of valuing Intellipharmaceutics by comparing valuation metrics of similar companies.Intellipharmaceutics is currently under evaluation in current liabilities category among its peers.
Intellipharmaceutics Fundamentals
| Return On Asset | -0.98 | |||
| Operating Margin | (106.06) % | |||
| Current Valuation | 4.47 M | |||
| Shares Outstanding | 33.09 M | |||
| Shares Owned By Insiders | 1.70 % | |||
| Shares Owned By Institutions | 11.09 % | |||
| Number Of Shares Shorted | 714 K | |||
| Price To Earning | (0.50) X | |||
| Price To Sales | 66.19 X | |||
| Gross Profit | 1.4 M | |||
| EBITDA | (4.45 M) | |||
| Net Income | (5.15 M) | |||
| Cash And Equivalents | 79.65 K | |||
| Total Debt | 2.01 M | |||
| Debt To Equity | 165.20 % | |||
| Current Ratio | 0.05 X | |||
| Book Value Per Share | (0.31) X | |||
| Cash Flow From Operations | (2.46 M) | |||
| Short Ratio | 0.39 X | |||
| Earnings Per Share | (0.16) X | |||
| Target Price | 25.0 | |||
| Number Of Employees | 11 | |||
| Beta | 1.0 | |||
| Market Capitalization | 2.02 M | |||
| Total Asset | 2.1 M | |||
| Retained Earnings | (86.55 M) | |||
| Working Capital | (5.62 M) | |||
| Current Asset | 1.41 M | |||
| Current Liabilities | 7.02 M | |||
| Z Score | -65.8 | |||
| Net Asset | 2.1 M |
Currently Active Assets on Macroaxis
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Other Consideration for investing in Intellipharmaceutics OTC Stock
If you are still planning to invest in Intellipharmaceutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Intellipharmaceutics' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |